Status:

COMPLETED

Laos Out-Of-Pocket Costs: an Observational Study on the Impact of Severe Childhood Illness on the Health, Wealth and Wellbeing of Household Members in Laos

Lead Sponsor:

Murdoch Childrens Research Institute

Collaborating Sponsors:

Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit

Conditions:

Health Care Economics

Child Health

Eligibility:

All Genders

1-15 years

Brief Summary

This will be a prospective longitudinal study of children attending hospital for treatment of a severe illness with community follow-up in Lao People's Democratic Republic (Lao PDR). The study aims to...

Detailed Description

This study aims to measure the out-of-pocket (OOP) expenses for households related to a severe acute illness/injury in children under five years presenting to hospitals in Lao PDR. Financial protectio...

Eligibility Criteria

Inclusion

  • Child is aged between 1 month -14 years 11 months at the time of admission/presentation to outpatient / ED / hospital
  • Child presents to or is admitted to hospital at one of the participating study site hospitals within the time period of the study
  • Child presents with symptoms of acute illness that started within the last 2 weeks (14 days) prior to hospital presentation. This will include children with a chronic illness but with new onset of symptoms within last 2 weeks.
  • Child is assessed by a health officer at the participating study site hospital and is deemed to have a "severe" illness/injury. A "severe" illness/injury will be defined as a child showing any emergency signs as outlined in the WHO Pocketbook, second edition:
  • OR Requires hospital admission/transfer to another health facility for further investigations and/or treatment for their acute illness/injury that cannot be performed in an outpatient setting or ED. This may include but is not limited to: transfer to another hospital with intensive care unit (ICU), intravenous (IV) medication or fluids; enteral nutrition; oxygen therapy; surgery.
  • • Parent/guardian has provided written informed consent, and will be available for the duration of the study follow-up period.

Exclusion

  • Child \<1 month or \>14 years 11 months at time of presentation to hospital
  • Child with symptoms that started \>2 weeks (\>14 days) prior to hospital presentation
  • Child admitted to the neonatal intensive care unit (NICU)
  • Child admitted to hospital for a planned procedure or planned treatment of a chronic medical condition (eg. Tonsillectomy, replacement of ventriculoperitoneal shunt or percutaneous endoscopic gastronomy (PEG) tube, tune up for cystic fibrosis, chemotherapy, palliative care),
  • Child already enrolled into this study from a previous hospital admission
  • Child discharged prior to screening and informed consent processes by study team members.

Key Trial Info

Start Date :

November 1 2022

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 10 2024

Estimated Enrollment :

400 Patients enrolled

Trial Details

Trial ID

NCT05239104

Start Date

November 1 2022

End Date

January 10 2024

Last Update

May 2 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Lao-Oxford-Mahosot-Hospital Wellcome Trust Research Unit (LOMWRU)

Vientiane, Laos